Establishes the PACE Task Force to study GLP-1 medications' history, accessibility, and insurance costs.
The bill creates the PACE Task Force to study GLP-1 medications' clinical history, accessibility, and insurance costs. The task force will propose recommendations for legislation, focusing on pricing differences, insurer spending, and coverage restrictions. The task force will submit its findings by February 12, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.